Foundation A, Measures A, Spertus J, Bonow R, Chan P, Diamond G, Drozda J, Kaul S, Krumholz H , Masoudi F, Normand S, Peterson E, Radford M, Rumsfeld J
others take 2-3 weeks Mild injection site reactions (if applicable) are common and self-limited Phase 3: Active Healing Phase (Weeks 3-8) Progressive improvement in symptoms For musculoskeletal conditions, this is the optimal window for physical therapy and rehabilitation For GI conditions, patients often begin reintroducing previously problematic foods Phase 4: Consolidation (Weeks 9-12+) Continued structural healing Transition to maintenance dosing if appropriate Decision point for stacking with TB-500 if additional systemic support is needed Phase 5: Transition and Maintenance Tapering off peptides after goal achievement Maintenance protocols for chronic conditions (e.g., 3 months on, 1 month off) Coordination with long-term wellness strategies (nutrition, exercise, stress management) For more information on conditions that may benefit from this approach, visit my Conditions Treated page
Shaded area represents dark period
35), suggesting a higher bioavailability of NP4 in comparison to Ru(II)-OH
